Lantheus Holdings (NASDAQ: LNTH) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic ...
In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Lantheus (LNTH – Research Report), with a price ...
Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Lantheus (LNTH – Research Report) and Argenx Se ...
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company ...
Lantheus Holdings Inc (NASDAQ:LNTH) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 ...
Lantheus (NASDAQ:LNTH – Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, ...
Explore the exciting world of Lantheus Holdings (NASDAQ: LNTH) with our expert analysts in this Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential ...
Lantheus Holdings Inc (LNTH) reports robust sales growth for PYLARIFY and DEFINITY, while navigating increased operating ...
Principal Financial Group Inc. reduced its position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 22.7% during the 4th quarter, according to the company in its most recent 13F ...
Lantheus Holdings expects full-year earnings in the range of $7 to $7.20 per share, with revenue in the range of $1.55 billion to $1.61 billion. This story was generated by Automated Insights ( http:/ ...
Welcome to the Lantheus Fourth Quarter and Full Year 2024 Conference Call. [Operator Instructions]. This call is being recorded and a replay will be available in the Investors section of the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results